santa cruz biotechnology, inc.

| |
|
| | EGFR Inhibitors
- AG 494
Potent inhibitor of epidermal growth factor receptor (EGFR) kinase (IC50 = 0.7 μM). Selective over ErbB2, PDGFR and insulin receptor kinase (IC50s are 42, 6 and >100 μM respectively).| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-202043 | 133550-35-3 | C16H12N2O3 | 10 mg/50 mg |
- AG 555
Potent epidermal growth factor receptor (EGFR) kinase inhibitor (IC50 = 0.7 μM) that displays 50-fold and >140-fold selectivity over ErbB2 and insulin receptor kinase respectively. Induce G1 growth arrest selectively in transformed cells (IC50 values are 6.4 and 9.4 μM in HPV16-immortalized and normal keratinocytes respectively).| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-203500 | 133550-34-2 | C19H18N2O3 | 10 mg/50 mg |
- AG 1478 hydrochloride
| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-361101 | 153436-53-4 | C16H14ClN3O2.HCl | 10 mg/50 mg |
- Tyrphostin AG 1478
A potent and selective inhibitor of EGFR; reported to block EGF-dependent src-family kinase activation and ERK phosphorylation.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200613 | 175178-82-2 | C16H14ClN3O2 | 5 mg/25 mg |
- BIBU 1361 dihydrochloride
Selective inhibitor of EGFR-kinase. Selectivity is exhibited over a range of other related tyrosine kinases. Blocks downstream signaling. Administration orally inhibits growth of established human xenografts in athymic mice.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-203844 | 793726-84-8 | C22H27ClFN7•2HCl | 1 mg/10 mg |
- BIBX 1382
Cell-permeable pyrimidopyrimidine. Potent, reversible, ATP-competitive, and highly selective inhibitor of EGFR (ErbB-1, HER-1) both in cell-free enzymatic reactions and in culture. | Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-202497 | 196612-93-8 | C18H19ClFN7 ·2HCl ·2H2O | 5 mg |
- DAPH
A tyrosine kinase inhibitor, which suppresses and reverses the formation of Aβ42 fibers in neurons.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200698 | 145915-58-8 | C20H15N3O2 | 5 mg |
- Erbstatin Analog
Inhibitor of EGFR (epidermal growth factor receptor)-associated tyrosine kinase. Blocks EGFR-mediated cellular phenotypic changes and delays EGF-induced DNA synthesis.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200511 | 63177-57-1 | C10H10O4 | 5 mg/25 mg |
- JNJ 28871063 hydrochloride
Potent and selective ErbB receptor family inhibitor (IC50 values are 21, 22 and 38 nM for ErbB4, EGFR and ErbB2 respectively). Displays potent growth inhibition of human cancer cell lines overexpressing ErbB2 in vitro (IC50= 60 - 168 nM). Inhibits growth of human tumor xenografts in vivo. Orally active and brain penetrant.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-204025 | 944341-54-2 | C24H27CIN6O3•HCl | 10 mg/50 mg |
- Lavendustin A
Inhibitor of the EGF receptor tyrosine kinase. Binds kinase on a site distinct from the ATP and peptide substrate binding sites. Suppresses VEGF-induced angiogenesis in rats.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200539 | 125697-92-9 | C21H19NO6 | 1 mg/5 mg |
- Lavendustin B
Lavendustin B is a weak tyrosine kinase inhibitor that can be used as a negative control for lavendustin A (sc-200539).| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200595 | 125697-91-8 | C21H19NO5 | 1 mg/5 mg |
- PD 153035
An extremely potent and specific inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor (EGFR).| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-205909 | 153436-54-5 (HCl salt) | C16H14BrN3O2 | 1 mg |
- PD 153035 Hydrochloride
An extremely potent inhibitor of epidermal growth factor (EGF) receptor tyrosine kinase (IC50 = 25 pM). Only inhibits other purified tyrosine kinases at micromolar or higher concentrations.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-205963 | 153436-54-5 | C16H14BrN3O2 ·HCl | 10 mg/50 mg |
- RG-13022
A tyrosine kinase tyrphostin. Reports indicate that it suppresses epidermal growth factor (EGF)-stimulated cancer cell proliferation in cancer cell studies.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200591 | 136831-48-6 | C16H14N2O2 | 5 mg/25 mg |
- Tyrphostin RG 14620
Non-phenolic tyrphostin analog, which is selective for the EGF receptor and long acting. Inhibits EGF-stimulated HER14 cell proliferation as well as tumor growth in vivo. | Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200593 | 136831-49-7 | C14H8Cl2N2 | 5 mg/25 mg |
- Tyrphostin B44, (+) enantiomer
Epidermal growth factor receptor (EGFR) kinase inhibitor. Slightly less active than the (-) enantiomer | Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-203305 | 133550-37-5 | C18H16N2O3 | 5 mg |
- Tyrphostin B44, (-) enantiomer
A potent inhibitor of epidermal growth factor receptor (EGFR) kinase (IC50 = 0.4 μM), more active than the (+) enantiomer. Selective over ErbB2.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-203711 | 133550-32-0 | C18H16N2O3 | 5 mg |
- Tyrphostin 47 (RG-50864, AG-213)
Tyrphostin 47 (RG-50864, AG-213) is a protein tyrosine kinase inhibitor particularly potent against epidermal growth factor (EGF) kinase activity.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200543 | 122520-86-9 | C10H8N2O2S | 5 mg/25 mg |
- Tyrphostin 51
A potent inhibitor of EGF receptor kinase activity (IC50=0.8 µM). Inhibition is mixed competitive with ATP and substrate.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200545 | 122520-90-5 | C13H8N4O3 | 5 mg/25 mg |
- Tyrphostin AG 99
Inhibits epidermal growth factor (EGF) receptor tyrosine kinase (IC50 = 10 µM) and EGF-dependent cell proliferation. Inhibits EGFR phosphorylation and ERK1 and ERK2 activities.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-202847 | 118409-59-9 | C10H8N2O3 | 5 mg/25 mg |
- Tyrphostin AG 183
Inhibits epidermal growth factor receptor tyrosine kinase (IC50 = 800 nM).| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-202846 | 126433-07-6 | C13H8N4O3 | 25 mg/5 mg |
|